NCT03266848

Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 15 (actual)
• Sponsor: Theranano LLC · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This trial will evaluate a non-invasive brain imaging technique QUTE-CE MRI and validate the method with first-in-human studies.

Detailed description

This trial will evaluate a non-invasive brain imaging technique QUTE-CE MRI using Ferumoxytol as a contrast agent, and validate the method with first-in-human studies. Subjects who are already scheduled to receive ferumoxytol infusion will undergo MRI scans after the infusion. The ferumoxytol infusion itself is not a part of the study. The project will provide brain angiograms and establish a human cerebrovascular atlas that will enable future quantitative diagnosis of cerebrovascular abnormalities by revealing abnormal regions of the brain that characterize disease, a tool which doesn't currently exist, and which could lead to many exciting discoveries and clinical applications in neurology.

Conditions

• Cerebrovascular Disorders

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Quantitative Magnetic Resonance Imaging	Radiological diagnosis

Timeline

• Start date: 2017-11-08
• Primary completion: 2020-07-22
• Completion: 2020-07-22
• First posted: 2017-08-30
• Last updated: 2021-08-24

Locations

1 site across 1 country: United States